Inactive Instrument

GreenLight Biosciences Holdings Share Price

Equities

GRNA

US39536G1058

Biotechnology & Medical Research

Dynamic Chart
Greenlight Biosciences Holdings Announces Resignation of Directors CI
GreenLight Biosciences Holdings(NasdaqGM:GRNA) dropped from NASDAQ Composite Index CI
GreenLight Biosciences Holdings(NasdaqGM:GRNA) dropped from S&P TMI Index CI
A group of buyers led by Fall Line Endurance Fund, Lp, managed by Fall Line Capital, LLC completed the acquisition of GreenLight Biosciences Holdings from stockholders. CI
GreenLight Biosciences Holdings announced that it has received $67.075 million in funding from a group of investors CI
GreenLight Biosciences Holdings(NasdaqGM:GRNA) dropped from NASDAQ Biotechnology Index CI
GreenLight Biosciences Holdings(NasdaqGM:GRNA) dropped from Russell Small Cap Comp Growth Index CI
GreenLight Biosciences Holdings(NasdaqGM:GRNA) dropped from Russell 2000 Index CI
GreenLight Biosciences Holdings(NasdaqGM:GRNA) dropped from Russell 3000 Growth Index CI
GreenLight Biosciences Holdings(NasdaqGM:GRNA) dropped from Russell Small Cap Completeness Index CI
GreenLight Biosciences Holdings(NasdaqGM:GRNA) dropped from Russell 2500 Growth Index CI
GreenLight Biosciences Holdings(NasdaqGM:GRNA) dropped from Russell 2000 Dynamic Index CI
GreenLight Biosciences Holdings(NasdaqGM:GRNA) dropped from Russell 3000E Growth Index CI
GreenLight Biosciences Holdings(NasdaqGM:GRNA) dropped from Russell 2000 Growth Index CI
GreenLight Biosciences Holdings(NasdaqGM:GRNA) dropped from Russell 2500 Index CI
More news
Managers TitleAgeSince
Chief Executive Officer 54 -
President - 24/23/24
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 54 -
President - 24/23/24
More insiders
GreenLight Biosciences Holdings, PBC is a pre-commercial stage biotechnology company. The Company has a cell-free ribonucleic acid (RNA) production platform for the discovery, development, and commercialization of products to promote healthier plants, foods, and people. The Company's cell-free biomanufacturing platform enables the making of complex biological molecules-nucleic acids, peptides, carbohydrates, and many others using fermentation. Its technology platform provides integrated discovery, design, and development of RNA-based products used in advanced pharma discovery to agriculture and human health. It has developed two manufacturing processes, one for plant health (dsRNA) and one for human health (mRNA) that both rely on synthesis of RNA from RNA building blocks, enzymes, and deoxyribonucleic acid (DNA) templates. The Company's plant program includes the Colorado Potato Beetle Program-Calantha; Varroa Mite Program, and Powdery Mildew Complex.
More about the company